Merck & Co., Inc. Profile Avatar - Palmy Investing

Merck & Co., Inc.

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immuno…
Drug Manufacturers - General
US, Kenilworth [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 14% Weak
Profitability n.A. n.A.
Fin. Growth 67% Positive
Leverage & Liquidity 17% Weak
Per Share Metrics 67% Positive
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q4 Q1 Δ in %
EV/EBITDA -88.39 52.22 449.94
Graham Fair Price 104.25 25.96 12.71
PEG -92.09 -0.04 0.45
Price/Book 11.87 8.22 7.35
Price/Cash Flow -59.95 148.85 -371.67
Prices/Earnings -69.07 17.42 -56.31
Price/Sales 11.19 20.99 18.88
Price/FCF -59.95 148.85 -371.67
Naive Interpretation member
01 - Valuation · Weak
Fundamentals

Profitability

Metric Q4 Q1 Δ in %
Gross Profit Margin -2.67 0.75 0.77
Operating Margin 1731.35 0.37 -0.02
ROA 291.45 0.04 -0.01
ROE -0.03 0.12 261.64
ROIC < 0.005 0.07 2616.91
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q4 Q1 Δ in %
Debt QOQ -0.06 0.04 39.77
Dividends QOQ < 0.005 0.05 130075.97
EBIT QOQ -1.05 20.79 1880.22
EPS QOQ -1.26 4.92 291.24
FCF QOQ -1.11 4.00 260.68
Revenue QOQ -0.08 0.08 -3.43
Naive Interpretation member
03 - Financial Growth · Positive
Fundamentals

Leverage & Liquidity

Metric Q4 Q1 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 171.32 148.89 -13.09
Days Sales Outstanding (DSO) 68.11 71.57 5.08
Inventory Turnover 0.53 0.60 15.06
Debt/Capitalization 0.48 0.46 -5.33
Quick Ratio 0.71 0.73 2.65
Naive Interpretation member
04 - Leverage & Liquidity · Weak
Fundamentals

Per Share Metrics

Metric Q4 Q1 Δ in %
Book Value 14.84 15.94 7.41
Cash 2.83 2.25 -20.25
Capex -0.39 -0.34 12.94
Free Cash Flow -0.29 0.88 200.00
Revenue 5.78 6.24 8.06
Naive Interpretation member
05 - Per Share Metrics · Positive
Fundamentals

Financial Health

Metric Q4 Q1 Δ in %
Current Ratio 1.25 1.25 0.07
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 43.24 4.14 -90.43
Naive Interpretation Member
06 - Financial Health · Weak